What Researchers Did
Researchers reviewed the known and theoretical tissue effects of hyperbaric oxygen therapy (HBOT) and discussed its potential role in treating perineal Crohn's disease.
What They Found
The review discussed that HBOT has shown beneficial effects in patients with severe or refractory perineal Crohn's disease. However, the optimal number of treatments and its role in larger or less severely affected patient groups remain undefined.
What This Means for Canadian Patients
Hyperbaric oxygen therapy could be a potential treatment option for severe or refractory perineal Crohn's disease. However, more research is needed to establish its efficacy, optimal dosage, and applicability for a broader range of patients before widespread use.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The review highlighted that the role of HBOT in larger patient groups, less severe cases, and the minimum number of treatments required for healing were not yet established.